Literature DB >> 20677173

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).

L Baseggio1, A Traverse-Glehen, E Callet-Bauchu, D Morel, J P Magaud, F Berger, G Salles, P Felman.   

Abstract

'Splenic red pulp lymphoma with numerous basophilic villous lymphocytes' (SRPL), recently described, is characterized by clinical, morphologic, immunologic, cytogenetic and molecular features distinct from SMZL/SLVL and HCL. In particular, the intensity of CD11c staining (expressed as fluorescence intensity -RFI-) in SRPL is significantly different from the RFI in SMZL/SLVL and HCL. Moreover the use of a scoring system based on the expression of CD11c, CD22, CD76, CD38 and CD27 appears to improve the differential diagnosis between SRPL and SMZL/SLVL and emphasizes that SRPL is an entity closed to but distinct from SMZL/SLVL.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20677173     DOI： 10.1002/hon.957

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


  8 in total

Review 1.  Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.

Authors:  Jérôme Paillassa; Elsa Maitre; Xavier Troussard
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

2.  Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.

Authors:  Elsa Maitre; Cécile Tomowiak; Benjamin Lebecque; Fontanet Bijou; Khaled Benabed; Dina Naguib; Pauline Kerneves; Edouard Cornet; Pierre-Julien Viailly; Jeffrey Arsham; Brigitte Sola; Fabrice Jardin; Xavier Troussard
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

Review 3.  Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.

Authors:  Jérôme Paillassa; Firas Safa; Xavier Troussard
Journal:  Ther Adv Hematol       Date:  2022-04-13

4.  Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Authors:  Laurent Jallades; Lucile Baseggio; Pierre Sujobert; Sarah Huet; Kaddour Chabane; Evelyne Callet-Bauchu; Aurélie Verney; Sandrine Hayette; Jean-Pierre Desvignes; David Salgado; Nicolas Levy; Christophe Béroud; Pascale Felman; Françoise Berger; Jean-Pierre Magaud; Laurent Genestier; Gilles Salles; Alexandra Traverse-Glehen
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

5.  Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

Authors:  Aurélie Verney; Alexandra Traverse-Glehen; Evelyne Callet-Bauchu; Laurent Jallades; Jean-Pierre Magaud; Gilles Salles; Laurent Genestier; Lucile Baseggio
Journal:  Oncotarget       Date:  2018-05-04

6.  New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.

Authors:  Elsa Maitre; Philippe Bertrand; Catherine Maingonnat; Pierre-Julien Viailly; Margaux Wiber; Dina Naguib; Véronique Salaün; Edouard Cornet; Gandhi Damaj; Brigitte Sola; Fabrice Jardin; Xavier Troussard
Journal:  Oncotarget       Date:  2018-06-22

7.  Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort.

Authors:  Michaël Degaud; Lucile Baseggio; Béatrice Grange; Delphine Manzoni; Sarah Huet; Evelyne Callet-Bauchu; Alexandra Traverse-Glehen; Frédéric Davi; Hervé Ghesquières; Gilles Salles; Pierre Sujobert
Journal:  Cancers (Basel)       Date:  2019-10-04       Impact factor: 6.639

Review 8.  A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.

Authors:  Elif Yilmaz; Arashpreet Chhina; Victor E Nava; Anita Aggarwal
Journal:  Curr Oncol       Date:  2021-12-06       Impact factor: 3.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.